<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-14T00:26:21Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.08425" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.08425</identifier>
    <datestamp>2024-05-13T15:02:47Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2024-05-13</dc:date>
  <dc:title>Table1 metabolites and metabolic pathways</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.08425</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>An ultra-high-pressure liquid chromatography system (Agilent 1290, USA) was used for the chromatography. In this experiment, the chromatographic column was ACQUITY UHPLC HSS T3 (1.8&amp;mu;m; 2.1&amp;times;100mm) (Waters). Formic acid was included in mobile phases A and B at a concentration of 0.1% in water and 0.1% in acetonitrile, respectively [24]. Elution was performed in the following manner: 5% B for 1 min, followed by 10% B within 1 min, followed by 95% B within 12 min, then held for 2 min. Within 1 minute, it was changed linearly to 5% B and held for 3 minutes. A temperature of 35&amp;deg;C was used for the analytical column and a temperature of 4&amp;deg;C was used for the autosampler. Each run consisted of 5 &amp;mu;L of sample, and the column eluent was analysed directly on the MS [24].The cecal contents (0.2g) was mixed with 4 volumes of methanol/acetonitrile (1:1, v/v) for analysis. After shaking for 30 seconds, all samples were ultrasonically treated for 10 minutes in an ice-cold water bath. A 2-hour incubation at -20&amp;deg;C was followed by 15 minutes at 4&amp;deg;C centrifugation with 13,000 x g to facilitate protein precipitation. A supernatant of cecal contents was collected, dried under vacuum, and centrifuged at 4&amp;deg;C. Following resuspension in 200 &amp;mu;L of methanol/acetonitrile (1:1), shaking for 30 s, and centrifugation at 13,000 x g for 15 minutes at 4&amp;deg;C, the aliquots were dried. The supernatant was analysed on a UHPLC system with a Q-TOF system (Agilent 6545, USA) using approximately 150 microliters. A quality control (QC) test was performed after each analysis of five samples.Data were obtained using the auto MS/MS mode from 50 to 1100 m/z. Collision energies for collision-induced dissociation were 20 V and 40 V. MS parameters were set as follows: ion source dry gas temperature, 320&amp;deg;C; N2 gas flow, 8L/min; sheath gas temperature, 350&amp;deg;C; sheath gas flow, 12 L/min; ion spray voltage, 4000 V (positive ion) and 3500 V (negative ion).The Analysis Base File Converter was used to convert data files from the Q-TOF-MS system to .abf format. The following parameters were used for peak detection, chromatogram deconvolution, and other data analyses: alignment-MS1 tolerance, 0.01 Da; retention time tolerance, 0.2 min; identification accurate mass tolerance (MS1), 0.005 Da; MS2, 0.05Da; identification score cut off, 60%. Metabolites and metabolic pathways were identified using HMDB (http://www.hmdb.ca/), METLIN (http://metlin.scripps.edu/), Massbank (http://www.massbank.jp) and KEGG (http://www.kegg.com/)&amp;nbsp;databases. In order to enhance precision, the identified metabolites were cross-validated utilizing a laboratory standard library.SIMCA-P software (version 14.1, Umetrics, Umea, Sweden) was used for the multivariate statistical analysis. A principal component analysis (PCA) was performed on the matrix imported into R to observe the overall distribution of samples and assess the stability of the whole process. Metabolites were distinguished between groups using partial least squares discriminant analysis (PLS-DA). Seven-fold cross-validation and 200 permutation tests (response permutation testing [RPT]) were performed to evaluate the model's quality. A&amp;nbsp;permutation test was used to assess the validity of the&amp;nbsp;model&amp;nbsp;and&amp;nbsp;its&amp;nbsp;degree of&amp;nbsp;overfitting. A VIP &amp;gt;1.0 and a p-value of 0.05 indicate that there is a significant difference. A p-value of .05 indicates that there is a significant difference between two groups compared using the Mann&amp;ndash;Whitney U test. For multiple groups, the false discovery rate (FDR) was applied (p &amp;lt; 0.10).&amp;nbsp;24.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;Zhao, X., et al., Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography-mass spectrometry. J Proteome Res, 2014. 13(2): p. 1101-11.</dc:description>
  <dc:subject>metabolic pathways; metabolites CL_ML_AN_FE and ; metabolites; ultra-high-pressure liquid chromatography; MS</dc:subject>
  <dc:creator>Cuoyou Chen</dc:creator>
  <dc:rights>RESTRICTED</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>